Approval For Expansion of Subzone 61E; Merck Sharpe & Dohme Quimica De Puerto Rico, Inc. (Pharmaceutical Products); Barceloneta, Puerto Rico, 62582 [E6-17969]
Download as PDF
<![CDATA[
62582
Federal Register / Vol. 71, No. 207 / Thursday, October 26, 2006 / Notices
DEPARTMENT OF COMMERCE
DEPARTMENT OF COMMERCE
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
Foreign-Trade Zones Board
Foreign-Trade Zones Board
[Order No. 1484]
[Order No. 1485]
[Order No. 1486]
Approval for Expansion of Subzone
35B, Merck & Company, Inc.,
(Pharmaceutical Products), West Point,
Pennsylvania
Approval For Expansion of Subzone
61D; Merck Sharpe & Dohme Quimica
De Puerto Rico, Inc. (Pharmaceutical
Products); Arecibo, Puerto Rico
Approval For Expansion of Subzone
61E; Merck Sharpe & Dohme Quimica
De Puerto Rico, Inc. (Pharmaceutical
Products); Barceloneta, Puerto Rico
Pursuant to its authority under the Foreign–
Trade Zones Act of June 18, 1934, as
amended (19 U.S.C. 81a–81u), the Foreign–
Trade Zones Board (the Board) adopts the
following Order:
Pursuant to its authority under the ForeignTrade Zones Act of June 18, 1934, as
amended (19 U.S.C. 81a–81u), the ForeignTrade Zones Board (the Board) adopts the
following Order:
Pursuant to its authority under the ForeignTrade Zones Act of June 18, 1934, as
amended (19 U.S.C. 81a–81u), the ForeignTrade Zones Board (the Board) adopts the
following Order:
WHEREAS, the Philadelphia Regional
Port Authority, grantee of FTZ 35, has
requested authority on behalf of Merck
& Company, Inc. (Merck), to expand the
subzone and scope of manufacturing
authority in terms of capacity at
Subzone 35B at the Merck
pharmaceutical manufacturing plant in
West Point, Pennsylvania (FTZ Docket
61–2005, filed 12/7/05); and,
WHEREAS, notice inviting public
comment has been given in the Federal
Register (70 FR 74290, 12/15/05);
WHEREAS, the Board adopts the
findings and recommendations of the
examiner’s report, and finds that the
requirements of the FTZ Act and the
Board’s regulations are satisfied, and
that approval of the application is in the
public interest;
NOW, THEREFORE, the Board hereby
approves the expansion of the subzone
and the scope of authority under zone
procedures in terms of capacity within
Subzone 35B for the manufacture of
pharmaceutical products at the Merck &
Company, Inc., plant located in West
Point, Pennsylvania, as described in the
application and the Federal Register
notice, subject to the FTZ Act and the
Board’s regulations, including § 400.28.
Signed at Washington, DC, this 20th
day of October 2006.
Whereas, the Puerto Rico Trade &
Export Company, grantee of FTZ 61, has
requested authority on behalf of Merck
Sharpe & Dohme Quimica De Puerto
Rico, Inc. (MSDQ), to expand the
subzone and scope of manufacturing
authority in terms of capacity at
Subzone 61D at the MSDQ
pharmaceutical manufacturing plant in
Arecibo, Puerto Rico (FTZ Docket 62–
2005, filed 12/7/05); and,
Whereas, notice inviting public
comment has been given in the Federal
Register (70 FR 74290, 12/15/05);
Whereas, the Board adopts the
findings and recommendations of the
examiner’s report, and finds that the
requirements of the FTZ Act and the
Board’s regulations are satisfied, and
that approval of the application is in the
public interest;
Now, therefore, the Board hereby
approves the expansion of the subzone
and the scope of authority under zone
procedures in terms of capacity within
Subzone 61D for the manufacture of
pharmaceutical products at the Merck
Sharpe & Dohme Quimica De Puerto
Rico, Inc., plant located in Arecibo,
Puerto Rico, as described in the
application and the Federal Register
notice, subject to the FTZ Act and the
Board’s regulations, including Section
400.28.
Whereas, the Puerto Rico Trade &
Export Company, grantee of FTZ 61, has
requested authority on behalf of Merck
Sharpe & Dohme Quimica De Puerto
Rico, Inc. (MSDQ), to expand the
subzone and scope of manufacturing
authority in terms of capacity at
Subzone 61E at the MSDQ
pharmaceutical manufacturing plant in
Barceloneta, Puerto Rico (FTZ Docket
63–2005, filed 12/7/05); and,
Whereas, notice inviting public
comment has been given in the Federal
Register (70 FR 74290, 12/15/05);
Whereas, the Board adopts the
findings and recommendations of the
examiner’s report, and finds that the
requirements of the FTZ Act and the
Board’s regulations are satisfied, and
that approval of the application is in the
public interest;
Now, therefore, the Board hereby
approves the expansion of the subzone
and the scope of authority under zone
procedures in terms of capacity within
Subzone 61E for the manufacture of
pharmaceutical products at the Merck
Sharpe & Dohme Quimica De Puerto
Rico, Inc., plant located in Barceloneta,
Puerto Rico, as described in the
application and the Federal Register
notice, subject to the FTZ Act and the
Board’s regulations, including § 400.28.
David M. Spooner,
Assistant Secretary of Commerce For Import
Administration, Alternate Chairman Foreign–
Trade Zones Board.
Attest:
Pierre V. Duy,
Acting Executive Secretary.
[FR Doc. E6–17972 Filed 10–25–06; 8:45 am]
ycherry on PROD1PC64 with NOTICES
BILLING CODE 3510–DS–S
Signed at Washington, DC, this 20th day of
October 2006.
David M. Spooner,
Assistant Secretary of Commerce for Import
Administration, Alternate Chairman, ForeignTrade Zones Board.
Attest:
Pierre V. Duy,
Acting Executive Secretary.
[FR Doc. E6–17968 Filed 10–25–06; 8:45 am]
Signed at Washington, DC, this 20th day of
October 2006.
David M. Spooner,
Assistant Secretary of Commerce for Import
Administration, Alternate Chairman, ForeignTrade Zones Board.
Attest:
Pierre V. Duy,
Acting Executive Secretary.
[FR Doc. E6–17969 Filed 10–25–06; 8:45 am]
BILLING CODE 3510–DS–P
BILLING CODE 3510–DS–P
VerDate Aug<31>2005
15:21 Oct 25, 2006
Jkt 211001
PO 00000
Frm 00002
Fmt 4703
Sfmt 4703
E:\FR\FM\26OCN1.SGM
26OCN1
]]>Agencies
[Federal Register Volume 71, Number 207 (Thursday, October 26, 2006)]
[Notices]
[Page 62582]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17969]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Order No. 1486]
Approval For Expansion of Subzone 61E; Merck Sharpe & Dohme
Quimica De Puerto Rico, Inc. (Pharmaceutical Products); Barceloneta,
Puerto Rico
Pursuant to its authority under the Foreign-Trade Zones Act of
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade
Zones Board (the Board) adopts the following Order:
Whereas, the Puerto Rico Trade & Export Company, grantee of FTZ 61,
has requested authority on behalf of Merck Sharpe & Dohme Quimica De
Puerto Rico, Inc. (MSDQ), to expand the subzone and scope of
manufacturing authority in terms of capacity at Subzone 61E at the MSDQ
pharmaceutical manufacturing plant in Barceloneta, Puerto Rico (FTZ
Docket 63-2005, filed 12/7/05); and,
Whereas, notice inviting public comment has been given in the
Federal Register (70 FR 74290, 12/15/05);
Whereas, the Board adopts the findings and recommendations of the
examiner's report, and finds that the requirements of the FTZ Act and
the Board's regulations are satisfied, and that approval of the
application is in the public interest;
Now, therefore, the Board hereby approves the expansion of the
subzone and the scope of authority under zone procedures in terms of
capacity within Subzone 61E for the manufacture of pharmaceutical
products at the Merck Sharpe & Dohme Quimica De Puerto Rico, Inc.,
plant located in Barceloneta, Puerto Rico, as described in the
application and the Federal Register notice, subject to the FTZ Act and
the Board's regulations, including Sec. 400.28.
Signed at Washington, DC, this 20th day of October 2006.
David M. Spooner,
Assistant Secretary of Commerce for Import Administration, Alternate
Chairman, Foreign-Trade Zones Board.
Attest:
Pierre V. Duy,
Acting Executive Secretary.
[FR Doc. E6-17969 Filed 10-25-06; 8:45 am]
BILLING CODE 3510-DS-P
